Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

Author： Griffiths R.I.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.5, 1999-05, pp. : 495-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy: A Focus on Methodological Issues

By Grzeskowiak Luke E.  

Drug Safety, Vol. 34, Iss. 11, 2011-11 ,pp. : 1027-1048

Adis International

Access to resources Recommend Favorite

Therapy-Resistant Psychotic-Depressive Disorder: Remission with a Selective Serotonin Reuptake Inhibitor in Combination with Olanzapine

By Braus D.F.  

Clinical Drug Investigation, Vol. 20, Iss. 6, 2000-12 ,pp. : 455-459

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression

By  

Current Pharmacogenomics, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Lack of adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine

By Nalepa I.   Manier D.H.   Gillespie D.D.   Rossby S.P.   Schmidt D.E.   Sulser F.  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 227-232

Elsevier

Access to resources Recommend Favorite

Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study

By Rosholm Jens-Ulrik   Andersen Morten   Gram Lars F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 923-929

Springer Publishing Company

Access to resources Recommend Favorite